News | July 17, 2025
Corona Remedies acquires 7 brands from Bayer's pharma division in India
This marks the fourth acquisition by Corona Remedies from multinational corporations
This marks the fourth acquisition by Corona Remedies from multinational corporations
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
The company’s largest center for medical device applications, serving the entire Asian market
To streamline complex medical writing workflows with GenAI
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Subscribe To Our Newsletter & Stay Updated
